Asia Pacific Poultry Vaccines Market Forecast to 2031
Asia Pacific Poultry Vaccines Market Forecast to 2031 – Regional Analysis – by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Marek’s Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Government Support for Mass Vaccination Drives and Innovative Schemes Boost Asia Pacific Poultry Vaccines Market
Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.
• In December 2022, the Indian Government announced launching of schemes such as the “Livestock Health & Disease Control Scheme” improve the animal health sector by implementing prophylactic vaccination programs against several diseases. This scheme is Central or State-driven and funded with a sharing pattern of 60:40. Also, the scheme covers “research & innovation, publicity & awareness, training & allied activities” that are 100% Center-funded.
Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.
Asia Pacific Poultry Vaccines Market Overview
The Asia Pacific poultry vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to grow considerably owing to factors such as the increasing incidences of livestock diseases, the rising incidences of zoonotic diseases, the presence of leading players, and initiatives taken by various government agencies and animal associations. Further, developing healthcare infrastructure and increasing per capita animal healthcare expenditure are projected to drive the Asia Pacific poultry vaccines market during the forecast period.
Asia Pacific Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Poultry Vaccines Market Segmentation
The Asia Pacific poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.
Based on type, the Asia Pacific poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.
In terms of technology, the Asia Pacific poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.
By dosage form, the Asia Pacific poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.
Based on disease, the Asia Pacific poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek’s disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.
In terms of route of administration, the Asia Pacific poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.
Based on end user, the Asia Pacific poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.
By country, the Asia Pacific poultry vaccines market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific poultry vaccines market share in 2023.
Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky’s (India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB. are some of the leading companies operating in the Asia Pacific poultry vaccines market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights’ research, the Asia Pacific poultry vaccines market was valued at US$ 752.66 million in 2023 and is anticipated to reach US$ 1,514.33 million by 2031, registering a CAGR of 9.1% from 2023 to 2031. Growing poultry industry and government support for mass vaccination drives & innovative schemes are among the critical factors attributed to drive the Asia Pacific poultry vaccines market growth.
According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world’s largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world’s poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.
On the contrary, vaccination failure and improper handling hamper the growth of Asia Pacific poultry vaccines market.
Based on type, the Asia Pacific poultry vaccines market is bifurcated into broiler and layer. The broiler segment held 64.1% market share in 2023, amassing US$ 482.36 million. It is projected to garner US$ 994.80 million by 2031 to register 9.5% CAGR during 2023-2031.
In terms of technology, the Asia Pacific poultry vaccines market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held 53.4% share of Asia Pacific poultry vaccines market in 2023, amassing US$ 401.72 million. It is projected to garner US$ 819.32 million by 2031 to register 9.3% CAGR during 2023-2031.
By dosage form, the Asia Pacific poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held 48.8% share of Asia Pacific poultry vaccines market in 2023, amassing US$ 367.07 million. It is projected to garner US$ 766.08 million by 2031 to expand at 9.6% CAGR from 2023 to 2031.
Based on type of disease, the Asia Pacific poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek’s disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held 27.1% share of Asia Pacific poultry vaccines market in 2023, amassing US$ 204.15 million. It is predicted to garner US$ 433.48 million by 2031 to expand at 9.9% CAGR between 2023 and 2031.
By route of administration, the Asia Pacific poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held 40.3% share of Asia Pacific poultry vaccines market in 2023, amassing US$ 303.17 million. It is estimated to garner US$ 636.30 million by 2031 to expand at 9.7% CAGR during 2023-2031.
In terms of end user, the Asia Pacific poultry vaccines market is categorized into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held 49.6% share of Asia Pacific hearing aids market in 2023, amassing US$ 373.65 million. It is projected to garner US$ 781.75 million by 2031 to expand at 9.7% CAGR from 2023 to 2031.
Based on country, the Asia Pacific poultry vaccines market is categorized into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 67.8% share of Asia Pacific poultry vaccines market in 2023. It was assessed at US$ 510.52 million in 2023 and is likely to hit US$ 1,043.61 million by 2031, registering a CAGR of 9.3% during 2023-2031.
Key players operating in the Asia Pacific poultry vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky’s (India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB, among others.
In December 2021, Venkys (India) set up a new project for the manufacturing of Veterinary Medicine Products under its Animal Health Product Segment. This plant will cover up to 600 Tones/Annum of veterinary medicine.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific poultry vaccines market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
4. Asia Pacific Poultry Vaccines Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Poultry Diseases
4.1.2 Growing Poultry Industry
4.2 Market Restraints
4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:
5. Asia Pacific Poultry Vaccines Market Analysis
5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031
6. Asia Pacific Poultry Vaccines Market Analysis – by Type
6.1 Overview
6.2 Broiler
6.2.1 Overview
6.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
6.3.1 Overview
6.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7. Asia Pacific Poultry Vaccines Market Analysis – by Technology
7.1 Overview
7.2 Live Attenuated Vaccines
7.2.1 Overview
7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
7.4.1 Overview
7.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Poultry Vaccines Market Analysis – by Dosage Form
8.1 Overview
8.2 Liquid Vaccines
8.2.1 Overview
8.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
8.3.1 Overview
8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
8.4.1 Overview
8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. Asia Pacific Poultry Vaccines Market Analysis – by Disease
9.1 Overview
9.2 Avian Influenza
9.2.1 Overview
9.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Avian Salmonellosis
9.3.1 Overview
9.3.2 Avian Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Marek’s Disease
9.4.1 Overview
9.4.2 Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
9.5.1 Overview
9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
9.6.1 Overview
9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
9.7.1 Overview
9.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. Asia Pacific Poultry Vaccines Market Analysis – by Route of Administration
10.1 Overview
10.2 Drinking Water (D/W)
10.2.1 Overview
10.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
10.3.1 Overview
10.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
10.4.1 Overview
10.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. Asia Pacific Poultry Vaccines Market Analysis – by End User
11.1 Overview
11.2 Poultry Farms
11.2.1 Overview
11.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
11.3.1 Overview
11.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers & Clinics
11.4.1 Overview
11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. Asia Pacific Poultry Vaccines Market – Country Analysis
12.1 Asia Pacific Market Overview
12.1.1 Poultry Vaccines Market Breakdown by Countries
12.1.1.1 China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 China: Poultry Vaccines Market Breakdown by Type
12.1.1.1.3 China: Poultry Vaccines Market Breakdown by Technology
12.1.1.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.1.5 China: Poultry Vaccines Market Breakdown by Disease
12.1.1.1.6 China: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.1.7 China: Poultry Vaccines Market Breakdown by End User
12.1.1.2 India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 India: Poultry Vaccines Market Breakdown by Type
12.1.1.2.3 India: Poultry Vaccines Market Breakdown by Technology
12.1.1.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.2.5 India: Poultry Vaccines Market Breakdown by Disease
12.1.1.2.6 India: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.2.7 India: Poultry Vaccines Market Breakdown by End User
12.1.1.3 Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 Japan: Poultry Vaccines Market Breakdown by Type
12.1.1.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
12.1.1.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
12.1.1.3.6 Japan: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.3.7 Japan: Poultry Vaccines Market Breakdown by End User
12.1.1.4 Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 Overview
12.1.1.4.2 Australia: Poultry Vaccines Market Breakdown by Type
12.1.1.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
12.1.1.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
12.1.1.4.6 Australia: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.4.7 Australia: Poultry Vaccines Market Breakdown by End User
12.1.1.5 South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
12.1.1.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
12.1.1.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
12.1.1.5.6 South Korea: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
12.1.1.6 Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 Overview
12.1.1.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
12.1.1.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
12.1.1.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
12.1.1.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route of Administration
12.1.1.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
13.3.1 Overview
13.1 Inorganic Developments
13.1.1 Overview
14. Company Profiles
14.1 Boehringer Ingelheim International GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Zoetis Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Phibro Animal Health Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Hester Biosciences Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Venky’s (India) Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Dechra Pharmaceuticals PLC
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Elanco Animal Health Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Merck KGaA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Ceva
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Nisseiken Co Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Vaccinova AB
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Research Team
15.2 Glossary of Terms
Table 1. Asia Pacific Poultry Vaccines Market Segmentation
Table 2. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 3. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 5. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 6. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 7. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 10. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 11. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 12. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 13. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 15. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 16. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 17. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 18. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 19. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 20. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 21. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 22. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 23. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 24. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 25. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 26. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 27. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 28. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 29. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 30. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 31. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 32. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 33. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 34. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 35. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 36. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 37. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 38. Organic Developments Done by Companies
Table 39. Inorganic Developments Done by Companies
Table 40. Glossary of Terms, Poultry Vaccines Market
Figure 1. Asia Pacific Poultry Vaccines Market Segmentation, by Country
Figure 2. Poultry Vaccines Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
Figure 5. Poultry Vaccines Market Share (%) – by Type, 2023 and 2031
Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 8. Poultry Vaccines Market Share (%) – by Technology, 2023 and 2031
Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 12. Poultry Vaccines Market Share (%) – by Dosage Form, 2023 and 2031
Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 16. Poultry Vaccines Market Share (%) – by Disease, 2023 and 2031
Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 19. Marek’s Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 24. Poultry Vaccines Market Share (%) – by Route of Administration, 2023 and 2031
Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 29. Poultry Vaccines Market Share (%) – by End User, 2023 and 2031
Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 33. Asia Pacific: Poultry Vaccines Market – Revenue by Key Countries 2023 (US$ Million)
Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 35. China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 36. India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 37. Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 38. Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 39. South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 40. Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 41. Growth Strategies in the Poultry Vaccines Market
The List of Companies – Asia Pacific Poultry Vaccines Market
o Boehringer Ingelheim International GmbH.
o Zoetis Inc.
o Phibro Animal Health Corp.
o Hester Biosciences Ltd.
o Venky’s (India) Ltd.
o Dechra Pharmaceuticals PLC.
o Elanco Animal Health Inc.
o Merck KGaA.
o Ceva.
o Nisseiken Co Ltd.
You must be logged in to post a review.
Reviews
There are no reviews yet.